CK-1827452: Preliminary Phase IIa data

Cytokinetics Inc. (NASDAQ:CYTK), South San Francisco, Calif. Product: CK-1827452 Business: Cardiovascular Molecular target: Not available Description: Cardiac myosin activator Indication: Treat hear...